"ex vivo" expanded autologous human oral epithelium containing stem cells
Cell therapyexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2021 (NCT05093166)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Stem CellTissue restoration
Stem Cell tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05093166 | Phase 1/Phase 2 (Phase 2) | Nov 30, 2021 | A.O. Ospedale Maggiore di Lodi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Holostem Terapie Avanzate s.r.l., University of Modena and Reggio Emilia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| A.O. Ospedale Maggiore di Lodi | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Holostem Terapie Avanzate s.r.l. | For profit | 1 | 1 | 1 | 2021 |
| University of Modena and Reggio Emilia | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1